Sunesis Pharmaceuticals Inc at Oppenheimer Healthcare Conference Transcript
Hey, everybody. Thanks for coming over here. This is the last session for the day today. So we have Sunesis, which is a Company I have known for a very long period of time and the CFO of the Company. I am going to give a little inside joke about Willie, which is that he is the true unicorn here at the Oppenheimer healthcare conference today, because he's a true (inaudible). And as you know, that market cap should be bigger than just about any other market cap out there. With that I will hand it off to Willie.
Thank you, Hartaj. So I'm going to give you an update on Sunesis today. I will be making some forward-looking statements, so please consult our regulatory filings for risk factors and more details.
Sunesis has a pipeline of kinase inhibitors and I joined the Company a little more than a year ago and for me this is what attracted me to Sunesis. They have some very interesting products. I'll spend most of my
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
